Published in Anticancer Res on March 27, 1997
Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer. Gut (2004) 0.89
Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives. Onco Targets Ther (2014) 0.89
p53 in rheumatoid arthritis: friend or foe? Arthritis Res (2000) 0.85
Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects? BMC Cancer (2009) 0.80
In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer. J Korean Med Sci (2004) 0.79
Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53. BMC Biotechnol (2002) 0.79
Glycerol as a chemical chaperone enhances radiation-induced apoptosis in anaplastic thyroid carcinoma cells. Mol Cancer (2002) 0.79
Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo. World J Gastroenterol (2016) 0.75
Virotherapy: cancer gene therapy at last? F1000Res (2016) 0.75
The minimal gene complement of Mycoplasma genitalium. Science (1995) 32.41
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med (1985) 8.21
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
VT/VF: 60/60 protection. Pacing Clin Electrophysiol (1990) 5.15
Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data. J Clin Microbiol (2002) 3.12
Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun (1997) 2.97
Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology (1992) 2.92
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol (2001) 2.91
Reactive pseudosarcomatous response in urinary bladder. Urology (1980) 2.89
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg (2000) 2.88
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol (1995) 2.62
Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem (2000) 2.51
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med (1996) 2.51
Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg (1995) 2.25
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Individual classification of mild cognitive impairment subtypes by support vector machine analysis of white matter DTI. AJNR Am J Neuroradiol (2012) 2.04
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys (1995) 2.03
Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst (1997) 2.01
Survival in early-stage non-small cell lung cancer. Ann Thorac Surg (1995) 2.01
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med (1983) 1.99
Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.97
Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.93
Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol (2000) 1.93
The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J Biol Chem (2001) 1.92
Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res (2001) 1.91
Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem (1996) 1.86
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst (1994) 1.83
Central visual field in diabetes. Br J Ophthalmol (1969) 1.83
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg (2000) 1.83
Specificity, stereochemistry, and mechanism of the color reaction between p-dimethylaminocinnamalhyde and biotin analogs. Anal Biochem (1970) 1.82
Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol (1999) 1.80
Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery (1999) 1.79
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol (1998) 1.78
Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res (1999) 1.78
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology (2007) 1.77
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol (1998) 1.76
Culture shock--a review of Vietnamese culture and its concepts of health and disease. West J Med (1985) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Psychiatric implications of tattoos. Am Fam Physician (1990) 1.63
Neutrophil activation by recombinant cytokines. Rev Infect Dis (1989) 1.63
In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest (1989) 1.60
Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest (1992) 1.59
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res (1994) 1.59
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst (2001) 1.55
Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology (1996) 1.54
Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by the total arrhythmic death rate. J Am Coll Cardiol (1991) 1.53
Case of Boerhaave's syndrome successfully treated with a self-expandable metallic stent. Gastrointest Endosc (1999) 1.52
Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics (2000) 1.51
Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol (1999) 1.50
Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg (1992) 1.49
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol (2009) 1.49
Synovial sarcoma of the neck: a followup study of 24 cases. Cancer (1975) 1.48
p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res (1991) 1.48
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst (1999) 1.47
Possible association of thymus dysfunction with fading syndromes in puppies and kittens. Vet Clin North Am Small Anim Pract (1987) 1.44
Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res (1993) 1.43
Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol (1993) 1.42
Gestational choriocarcinoma in the fallopian tube. J Obstet Gynaecol (2013) 1.42
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys (1995) 1.40
Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery (1997) 1.40
Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. Ann Intern Med (1992) 1.39
Release of 5'-guanosine monophosphate and adenine by Brucella abortus and their role in the intracellular survival of the bacteria. J Infect Dis (1986) 1.39
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer (1989) 1.38
Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Cancer Res (2000) 1.37
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med (2001) 1.37
Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. Carcinogenesis (1988) 1.37
Occurrence of Shiga-like toxin-producing Escherichia coli in retail fresh seafood, beef, lamb, pork, and poultry from grocery stores in Seattle, Washington. Appl Environ Microbiol (1994) 1.36
Biology of human papillomaviruses. Int J Exp Pathol (2001) 1.31
Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thorac Surg (1991) 1.31
Some contingencies of the moral evaluation and control of clientele: the case of the hospital emergency service. AJS (1972) 1.30
Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. Oncogene (1995) 1.30
Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res (1998) 1.29
Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem (2000) 1.29
Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer (1992) 1.28
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol (1993) 1.28
Evaluation of bovine polymorphonuclear leukocyte function. Vet Immunol Immunopathol (1981) 1.27
Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res (1989) 1.24
Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer (1997) 1.23
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
New approaches in imaging of the brachial plexus. Eur J Radiol (2010) 1.23
Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc Res Tech (2000) 1.23
Clips versus suture technique: is there a difference? Can J Cardiol (2000) 1.23
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene (2001) 1.22
Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther (2000) 1.22
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res (1996) 1.21
The laparoscopic approach for repair of Morgagni hernias. JSLS (1999) 1.21
Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res (2001) 1.20
Acculturation style and psychological functioning in children of immigrants. Am J Orthopsychiatry (1996) 1.20
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol (1990) 1.20
Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res (2001) 1.20
Guanethidine and adrenaline used in combination in chronic simple glaucoma. Br J Ophthalmol (1973) 1.19
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol (1999) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. J Thorac Cardiovasc Surg (2001) 1.19
Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection. Vet Pathol (2000) 1.18
Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg (1984) 1.18
Reoperative pulmonary resection in patients with metastatic soft tissue sarcoma. Ann Thorac Surg (1991) 1.18
Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep. Neuroscience (2008) 1.17